A detailed history of Strs Ohio transactions in Amgen Inc stock. As of the latest transaction made, Strs Ohio holds 164,384 shares of AMGN stock, worth $48.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
164,384
Previous 173,467 5.24%
Holding current value
$48.4 Million
Previous $54.2 Million 2.27%
% of portfolio
0.21%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$309.38 - $337.38 $2.81 Million - $3.06 Million
-9,083 Reduced 5.24%
164,384 $53 Million
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $1.31 Million - $1.6 Million
-5,003 Reduced 2.8%
173,467 $54.2 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $4.39 Million - $5.3 Million
-16,345 Reduced 8.39%
178,470 $50.7 Million
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $1.16 Million - $1.31 Million
-4,553 Reduced 2.28%
194,815 $56.1 Million
Q3 2023

Oct 26, 2023

SELL
$218.65 - $271.46 $1.16 Million - $1.44 Million
-5,295 Reduced 2.59%
199,368 $53.6 Million
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $43.9 Million - $51.9 Million
204,663 New
204,663 $45.4 Million
Q1 2023

Aug 02, 2023

BUY
$225.79 - $275.2 $2.22 Million - $2.71 Million
9,852 Added 4.81%
214,515 $51.9 Million
Q4 2022

Jan 26, 2023

BUY
$229.03 - $291.01 $1.39 Million - $1.77 Million
6,073 Added 2.9%
215,553 $56.6 Million
Q3 2022

Oct 27, 2022

SELL
$224.46 - $253.15 $3.51 Million - $3.96 Million
-15,628 Reduced 6.94%
209,480 $47.2 Million
Q2 2022

Jul 25, 2022

SELL
$230.71 - $256.74 $3.97 Million - $4.42 Million
-17,218 Reduced 7.11%
225,108 $54.8 Million
Q1 2022

Apr 21, 2022

BUY
$219.27 - $242.57 $552,341 - $611,033
2,519 Added 1.05%
242,326 $58.6 Million
Q4 2021

Jan 24, 2022

BUY
$198.88 - $227.6 $12.6 Million - $14.5 Million
63,504 Added 36.02%
239,807 $53.9 Million
Q3 2021

Oct 22, 2021

SELL
$212.27 - $248.7 $3.66 Million - $4.29 Million
-17,255 Reduced 8.91%
176,303 $37.5 Million
Q2 2021

Jul 26, 2021

SELL
$233.58 - $259.14 $4.19 Million - $4.64 Million
-17,917 Reduced 8.47%
193,558 $47.2 Million
Q1 2021

Apr 23, 2021

SELL
$221.91 - $258.6 $8.88 Million - $10.3 Million
-40,020 Reduced 15.91%
211,475 $52.6 Million
Q4 2020

Jan 25, 2021

SELL
$216.38 - $257.67 $5.66 Million - $6.74 Million
-26,161 Reduced 9.42%
251,495 $57.8 Million
Q3 2020

Dec 14, 2020

SELL
$234.65 - $260.95 $6.33 Million - $7.04 Million
-26,962 Reduced 8.85%
277,656 $70.6 Million
Q2 2020

Jul 23, 2020

BUY
$197.81 - $242.74 $916,058 - $1.12 Million
4,631 Added 1.54%
304,618 $71.8 Million
Q1 2020

Apr 23, 2020

BUY
$182.24 - $241.7 $6.82 Million - $9.04 Million
37,417 Added 14.25%
299,987 $60.8 Million
Q4 2019

Jan 24, 2020

SELL
$189.21 - $243.2 $3.82 Million - $4.92 Million
-20,214 Reduced 7.15%
262,570 $63.3 Million
Q3 2019

Oct 21, 2019

SELL
$174.11 - $208.62 $1.61 Million - $1.93 Million
-9,242 Reduced 3.16%
282,784 $54.7 Million
Q2 2019

Jul 25, 2019

SELL
$166.7 - $195.41 $1.8 Million - $2.11 Million
-10,811 Reduced 3.57%
292,026 $53.8 Million
Q1 2019

Apr 19, 2019

SELL
$180.87 - $203.88 $1.34 Million - $1.51 Million
-7,401 Reduced 2.39%
302,837 $57.5 Million
Q4 2018

Jan 23, 2019

SELL
$178.4 - $208.25 $328,969 - $384,013
-1,844 Reduced 0.59%
310,238 $60.4 Million
Q3 2018

Oct 19, 2018

SELL
$185.29 - $208.89 $13.2 Million - $14.9 Million
-71,122 Reduced 18.56%
312,082 $64.7 Million
Q2 2018

Aug 06, 2018

SELL
$166.05 - $186.51 $6.35 Million - $7.13 Million
-38,227 Reduced 9.07%
383,204 $70.7 Million
Q1 2018

Apr 20, 2018

SELL
$169.43 - $198.0 $3.74 Million - $4.37 Million
-22,088 Reduced 4.98%
421,431 $71.8 Million
Q4 2017

Jan 23, 2018

SELL
$168.79 - $188.59 $1.46 Million - $1.63 Million
-8,627 Reduced 1.91%
443,519 $77.1 Million
Q3 2017

Oct 23, 2017

BUY
$167.29 - $191.0 $75.6 Million - $86.4 Million
452,146
452,146 $84.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.